ووشي آپ‌تك

ووشي آپ‌تك
النوعخاصة
الصناعةContract Research Organizations
Pharmaceutical
Biopharmaceutical
Medical Devices
تأسست2000
المقر الرئيسيشانغهاي، الصين
عدد المواقع
18 منها الصين (شانغهاي، سوژو، ووشي، ووهان، تيان‌جين، تشانگ‌ژو، نان‌جينگالولايات المتحدة (سانت پول، منيسوتا، سان دييگو، فيلادلفيا، أطلنطا، پلينزبورو، نيوجرزي، كمبردج، مساتشوستسأيسلندا (ريكياڤيكإسرائيل (تل أبيبكوريا الجنوبية (سونگ‌نامألمانيا (ميونخ)
الأشخاص الرئيسيون
گى لي (الرئيس التنفيذي) Al Guerrini
المنتجات
  • خدمات الاكتشاف
  • قسم الاختبارات المعملية (LTD)
  • API Development and Manufacturing (STA)
  • خدمات التطوير
  • WuXi Biologics
  • خدمات العلاج الخلوي والجيني
  • U.S. Medical Device Services
  • خدمات الكيمياء
  • خدمات علم السميات
  • Bioanalytical Services
  • Clinical and Regulatory Services
  • Genomics and molecular diagnostics
  • Biological Reagents
الموظفون>18,000 (2017) [1]
الموقع الإلكترونيOfficial website

مجموعة ووشي آپ‌تك WuXi AppTec ‏ هي leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform company with global operations. As an innovation-driven and customer-focused company, WuXi AppTec Group provides a broad and integrated portfolio of services to help our worldwide customers and partners shorten the discovery and development time and lower the cost of drug and medical device R&D through cost-effective and efficient solutions. With its industry-leading capabilities in small molecule R&D and manufacturing, biologics R&D and manufacturing, cell therapy and gene therapy R&D and manufacturing, medical device testing, and molecular testing and genomics, WuXi platform is enabling more than 3,000 innovative collaborators from more than 30 countries to bring innovative healthcare products to patients, and to fulfill WuXi AppTec Group’s dream that “every drug can be made and every disease can be treated.”

WuXi AppTec is building an alternative R&D engine to serve the global health industry.[2]

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

التاريخ

مؤسس ووشي، الدكتور گى لي، حصل على شهادة الدكتوراه في الكيمياء العضوية من جامعة كلومبيا, and was a founding scientist at Pharmacopeia, Inc. of Princeton, New Jersey, then returned to China to found WuXi PharmaTech in Shanghai in December 2000.

WuXi Group established services in synthetic chemistry in 2001, manufacturing process development in 2003, research manufacturing in 2004, bioanalytical services in 2005, service biology in 2006, and toxicology and formulation in 2007. On December 14, 2006, WuXi PharmaTech, announced that it was named 173rd on the Deloitte Technology Fast 500 Asia Pacific 2006 ranking[3] The company opened chemistry facilities in Tianjin in 2007. In 2008, WuXi PharmaTech acquired AppTec Laboratory Services Inc., a US-based company founded in 2001 with expertise in medical-device and biologics testing and with facilities in St. Paul, MN; Philadelphia, PA; and Atlanta, GA. WuXi opened a toxicology facility in Suzhou in 2009.[4]


الهامش

  1. ^ "WuXi AppTec - About". WuXi AppTec. Retrieved 12 July 2017.
  2. ^ "WuXi Apptec - Company Overview". WuXi AppTec. Retrieved 12 July 2017.
  3. ^ "WuXi PharmaTechListed Among Asia's Fastest Growing Companies, Third Year Running".
  4. ^ "WuXi Apptec's History". WuXi AppTec. Retrieved 12 July 2017.
  5. ^ WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2012 Results
  6. ^ WuXi PharmaTech Announces First-Quarter 2013

وصلات خارجية

الكلمات الدالة: